Clinical trial

Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder

NCT00514865

Study summary

ClinicalTrials.gov

Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention ONO-2333Ms Experimental 2 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention ONO-2333Ms Experimental 1 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-06-13

PhasePHASE2

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

ONO-2333Ms Experimental 2DRUG

PlaceboDRUG

ONO-2333Ms Experimental 1DRUG

Sponsors & collaborators

Ono Pharma USA Inclead sponsor

Mapped research locations

AtlantaGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00514865 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.